Resources

Which implants do we insert?

At our Clinic we insert the OSSEOTITE dental implant from 3i.  It is a high range implant which, according to scientific studies, provides the best results.  In accordance with the Clinic’s philosophy, we aim to provide the very best treatments to all those who place their trust in us for their care.

On this page we summarise some of the features of this implant.  At times the language may be a little too technical.  If you have any queries, please do not hesitate to contact us.

OSEEOTITE implants have revolutionised implant technology due to their surface treatment and have led to an overall global success rate of 98.6% for this treatment.  In the light of these results the FDA (Food and Drugs Administration) indicates that the Osseotite is the implant of choice for all types of bone.

.In addition, due to the specific characteristics of these implants the period of osseointegration is shorter, which has facilitated the shortening of the overall implant treatment.

Osseotite is the first implant of hybrid design.  It combines a surface area of 3mm of refined titanium on the coronal area, which maintains the health of the mucous tissue, with the surface of the remainder of the implant being microtextured OSSEOTITE, exclusive to 3i.  This surface increases adherence to the bone and the percentage of osseous contact.

A new unique surface without contaminants

Double etching with hydrochloric and sulphuric acid is the most reliable method for obtaining a uniformly rough surface with distant peaks of 0.3-1,5 and a depth of 1-2.  These dimensions are determining factors in the retention capacity of the clot and the formation of the osseous matrix (Wong et cols. 1995).

Smooth planed Titanium surface	.Surface with hydroxyapatite coating	.Surface with titanium plasma spray
Stained surface	Surface etched in acid with nitric and fluorhydric acid.	. Surface etched with hydrochloric and sulphuric acid.

Clinical research confirms that OSSEOTITE improves the results.

Numerous studies demonstrate the clinical advantages of the clotting retention capacity and the subsequent increase in contact osteogenesis of the OSSEOTITE surface.

In a recent study the results of 220 OSSEOTITE implants were compared with 238 implants of mechanised surface – which is the one normally used – placed on the posterior part of the maxilla.  In this study of implants placed on low quality areas of bone, OSSEOTITE implants present a clinical success rate some 11% above that of implants with mechanised surface after 24 months (98,6% for OSSEOTITE against 87,6% for mechanised implants).  The data indicates better clinical results due to the greater contact osteogenesis achieved with the OSSEOTITE surface

The hystomorphometry in patients confirms greater bone-implant contact and contact osteogenesis

The histology study provided additional data about how the surface of implants affects the osteogenesis process.   Some special implants were prepared: short screws of 2mm diameter, on one side had OSSEOTITE surface and on the other a smooth mechanised surface.  They were placed in the maxillary tubercle of patients during conventional implant surgery and were extracted after 6 months scarring.

The thirty nine histological sections carried out showed an average percentage of osseous contact with OSSEOTITE of 72,96% compared with 33,98% for the mechanised surface.